PharmiWeb.com - Global Pharma News & Resources

Research and development - Press Releases

Date Title Company
15-Aug-2023 Refeyn Expands into AAV-based Gene Therapy Manufacturing with GMP Software Refeyn
15-Aug-2023 Key Enzyme for Drug Metabolism Exhibits Soft Robotic Properties Which Could Lead to Advanced Biogels and Polymers, According to Hebrew University Researchers Hebrew University of Jerusalem (HU)
15-Aug-2023 Amicus Therapeutics Announces Approval and Launch of New Pompe Disease Therapy in the United Kingdom Amicus Therapeutics
15-Aug-2023 Novel biologic Ab-IPL-IL-17™ shows promise for rheumatoid arthritis and inflammatory bowel disease About the University of Birmingham
15-Aug-2023 IMPROVING PATIENT SAFETY AND OUTCOMES: EU-HYPROTECT REGISTRY DEMONSTRATES REDUCED TIME IN HYPOTENSION DURING SURGERY USING ACUMEN HPI SOFTWARE Edwards Lifesciences
15-Aug-2023 Definitive Proxy Statement and Prospectus Mailed by Rosecliff Acquisition Corporation I Spectral MD Holdings, Ltd
15-Aug-2023 ISO 13485 Certification Received for AI-Driven DeepView® Wound Imaging System Spectral MD Holdings, Ltd
15-Aug-2023 Filing of Updated Form S-4 by Rosecliff & Updated Investor Presentation Spectral MD Holdings, Ltd
15-Aug-2023 Anti-Ageing Clinic in Space – Lycotec Project Lycotec
12-Aug-2023 Alfa Chemistry Provides Cutting-Edge MS and NMR Services for Research and Pharmaceutical Support Alfa Chemistry
09-Aug-2023 AlzeCure publishes the positive clinical results from the phase I trial of NeuroRestore ACD856 against Alzheimer's AlzeCure Pharma AB
07-Aug-2023 CAS Welcomes Early-Career Scientists for the 2023 Future Leaders Program CAS
03-Aug-2023 TrialAssure Announces AI Generative Text Partnership with Top Clinical Research Organization MMS on New Medical Writing Initiative TrialAssure
01-Aug-2023 TG Therapeutics and Neuraxpharm Announce Ex-US Commercialization Agreement for BRIUMVI® (ublituximab-xiiy) TG Therapeutics
01-Aug-2023 Eshelman Institute for Innovation establishes research collaboration with Aston University Aston University
01-Aug-2023 Terumo Blood and Cell Technologies’ Reveos(R) Automated Whole Blood Processing System cleared by FDA for US commercial use Terumo Blood and Cell Technologies
01-Aug-2023 Exploring the Technological Advancements in Glycated Albumin Assay Testing Methods Markets and Markets
01-Aug-2023 PureTech Awarded up to $11.4 Million from U.S. Department of Defense to Advance LYT-300 (Oral Allopregnanolone) for Fragile X-associated Tremor/Ataxia Syndrome PureTech
01-Aug-2023 TG Therapeutics and Neuraxpharm Announce Ex-US Commercialization Agreement for BRIUMVI® (ublituximab-xiiy) TG Therapeutics
01-Aug-2023 Updated Investor Presentation & Filing by Rosecliff Acquisition Corp. I Spectral MD Holdings, Ltd